Hemolytic disease of the newborn laboratory findings

Hemolytic disease of the newborn Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemolytic disease of the newborn from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hemolytic disease of the newborn laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemolytic disease of the newborn laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemolytic disease of the newborn laboratory findings
CDC on Hemolytic disease of the newborn laboratory findings
Hemolytic disease of the newborn laboratory findings in the news
Blogs on Hemolytic disease of the newborn laboratory findings
Directions to Hospitals Treating Hemolytic disease of the newborn
Risk calculators and risk factors for Hemolytic disease of the newborn laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Laboratory Findings

• ABO system
  • ABO hemolytic disease of the newborn can range from mild to severe, but generally it is a mild disease.
    • Anti-A antibodies
    • Anti-B antibodies

• Rhesus system (the Rh d antigen and Rh d antibodies do not exist)
  • Rhesus D hemolytic disease of the newborn (often called Rh disease) is the most common form of severe HDN. The disease varies from mild to severe.
  • Rhesus E hemolytic disease of the newborn is a mild condition
  • Rhesus c hemolytic disease of the newborn can range from a mild to severe disease - is the third most common form of severe HDN
  • Rhesus e hemolytic disease of the newborn - rare
  • Rhesus C hemolytic disease of the newborn - rare
  • Antibody combinations (ie anti-Rhc and anti-RhE antibodies occurring together) - can be severe

• Kell system
  • Anti-Kell hemolytic disease of the newborn
    • Anti-K ₁ antibodies - disease ranges from mild to severe - over half of the cases are caused by multiple blood transfusions - is the second most common form of severe HDN
    • Anti-K ₂ ,anti-K ₃ and anti-K ₄ antibodies - rare

• Other blood group antibodies (Kidd, Lewis, Duffy, MN, P and others).

Not to be confused with Haemorrhagic disease of the newborn.

The diagnosis of HDN is based on history and laboratory findings:

Blood tests done on the newborn baby

• Biochemistry tests for jaundice
• Peripheral blood morphology shows increased reticulocytes. Erythroblasts (also known as nucleated red blood cells) occur in moderate and severe disease.

• Positive direct Coombs test (might be negative after fetal interuterine blood transfusion)

Blood tests done on the mother

• Positive indirect Coombs test